GZI: Stimulator, Neuromuscular, External Functional
What it covers
An external functional neuromuscular stimulator is an electrical stimulator that uses external electrodes for stimulating muscles in the leg and ankle of partially paralyzed patients (e.g., after stroke) to provide flexion of the foot and thus improve the patient's gait.
The identification in 21 CFR 882.5810, external functional neuromuscular stimulator. FDA gives GZI no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K242704 | Synchrony (20-3000) | Synapse Biomedical, Inc. | Jun 5, 2025 | Traditional |
| K243828 | CIONIC NEURAL SLEEVE (NS-200) | Cionic, Inc. | May 2, 2025 | Traditional |
| K240632 | Neuvotion NeuStim NN-01 | Neuvotion, Inc. | Nov 22, 2024 | Traditional |
| K233006 | MyndMove, MyndMove 2.0 | Myndtec, Inc. | Jun 25, 2024 | Traditional |
| K230997 | EvoWalk 1.0 System | Evolution Devices, Inc. | Dec 28, 2023 | Traditional |
| K221823 | Cionic Neural Sleeve NS-100 | Cionic | Jul 21, 2022 | Special |
| K213925 | MyoCycle MC-2 (Home / Home + / Pro / Pro +) | Myolyn, LLC | Apr 25, 2022 | Traditional |
| K212149 | MyndMove 2.0 | Myndtec, Inc. | Mar 3, 2022 | Traditional |
| K213622 | Cionic Neural Sleeve NS-100 | Cionic | Feb 14, 2022 | Traditional |
| K202110 | MStim Drop Model: LGT-233 | Guangzhou Longest Science & Technology Co., Ltd. | Nov 5, 2021 | Traditional |
Clearances by year
37 GZI 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2025 | 2 | 205 |
| 2024 | 2 | 269 |
| 2023 | 1 | 265 |
| 2022 | 4 | 110 |
| 2021 | 1 | 463 |
| 2020 | 2 | 166 |
| 2019 | 2 | 61 |
| 2018 | 2 | 182 |
| 2017 | 6 | 168 |
| 2016 | 1 | 157 |
| 2015 | 1 | 269 |
| 2014 | 3 | 299 |
| 2013 | 2 | 128 |
| 2012 | 2 | 69 |
| 2011 | 6 | 139 |
Who submits
18 applicants cleared a GZI device since 2011. 62% of the clearances went to applicants in United States, then Canada (11%), China (8%) and Germany (8%). By type: Traditional 86% and Special 14%.
| Applicant | Clearances since 2011 |
|---|---|
| Bioness, Inc. | 9 |
| Hasomed GmbH | 3 |
| Myndtec, Inc. | 3 |
| Restorative Therapies, Inc. | 3 |
| Cionic | 2 |
| Innovative Neurotronics, Inc. | 2 |
| Myolyn, LLC | 2 |
| Odstock Medical, Ltd. | 2 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 882.5810.
Standards
21 CFR 882.5810 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent GZI clearances declared.
Ask about GZI
Questions about GZI
What is FDA product code GZI?
Product code GZI, “Stimulator, Neuromuscular, External Functional” in FDA's classification database, is a Class II device type under 21 CFR 882.5810 (external functional neuromuscular stimulator), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 61 clearances under GZI, 37 of them since 2011.
How many 510(k) clearances are there under GZI?
FDA’s 510(k) database listed 61 clearances under GZI as of Oct 29, 2026, 37 of them decided since 2011; the most recent decision was Jun 5, 2025. The Predicate Finder searches the live database.
How long does FDA take to clear a GZI 510(k)?
For the 3 GZI clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 261 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most GZI clearances?
Since 2011: Bioness, Inc. (9), Hasomed GmbH (3), Myndtec, Inc. (3), Restorative Therapies, Inc. (3) and Cionic (2). 18 applicants have cleared a GZI device in that time.